Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...

Researchers, including experts from the University of Missouri School of Medicine, explored the use of senolytics—drugs ...

The global continuous positive airway pressure (CPAP) market is projected to reach a value of USD 900 million by 2033, ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...

Continuous positive airway pressure (CPAP) therapy is a treatment for sleep apnea that uses a constant flow of air to keep the airway open while a person sleeps. To keep machines clean, doctors ...

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

Sundayjn to highlight the potential of Bubble Continuous Positive Airway Pressure (bCPAP), a locally manufactured, low-cost ...

After one year, 42% of Zepbound users without PAP therapy and 50% with PAP therapy achieved remission or mild, non-symptomatic OSA, compared to 16% and 14% in placebo groups, respectively.